Literature DB >> 1558741

Effects of postnatal ganglioside administration and hypoxia-exposure on the dopamine release from striatal slices, the behaviour and the ganglioside pattern of 2-3 months old rats.

B Brux1, K Ogawa, C Berndt, C Wustmann, H D Fishcer, A Lun, T Abe, J Gross.   

Abstract

Neonatal rats were injected with a mixture of bovine brain gangliosides (30 mg/kg body weight, s.c.) immediately before the exposure to hypoxia (pO2 = 10 kPa, 10 hrs daily) from the 2nd to the 11th day of life. At the age of 2-3 months the potential protective or restitutive effect of gangliosides on the radiolabelled dopamine release from striatal slices and on the conditioned avoidance learning was studied. No change in the content and the pattern of gangliosides of the rat striata was found after exposure to hypoxia and ganglioside administration, respectively. Both hypoxia exposure and ganglioside treatment of controls increased the dopamine release whereas hypoxic animals treated with gangliosides showed a diminished release. Hypoxia-induced impaired conditioned avoidance learning was improved by ganglioside treatment. The changed release of dopamine and the altered behavioural performance after ganglioside treatment alone indicate the necessity of a very cautious application of gangliosides to the developing brain.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1558741     DOI: 10.1007/bf01245012

Source DB:  PubMed          Journal:  J Neural Transm Gen Sect


  14 in total

1.  Quantitative estimation of sialic acids. II. A colorimetric resorcinol-hydrochloric acid method.

Authors:  L SVENNERHOLM
Journal:  Biochim Biophys Acta       Date:  1957-06

2.  Effect of early and late postnatal hypoxia on subcellular synaptosomal fractions from cerebral cortex of rats. I. An electron-microscopical and biochemical study.

Authors:  U Meyer; W Ihle; R Moller; J Odarjuk; J Wenzel; J Gross
Journal:  J Hirnforsch       Date:  1986

3.  Metabolism and function of gangliosides in developing neurons.

Authors:  H Dreyfus; B Ferret; S Harth; A Gorio; M Durand; L Freysz; R Massarelli
Journal:  J Neurosci Res       Date:  1984       Impact factor: 4.164

4.  Brain biochemical and behavioral changes in 4 weeks old rats after neonatal oxygen deprivation.

Authors:  T Hedner; P Lundborg; J Engel
Journal:  Pharmacol Biochem Behav       Date:  1979-05       Impact factor: 3.533

5.  Ganglioside-mediated modulation of cell growth. Specific effects of GM3 on tyrosine phosphorylation of the epidermal growth factor receptor.

Authors:  E G Bremer; J Schlessinger; S Hakomori
Journal:  J Biol Chem       Date:  1986-02-15       Impact factor: 5.157

6.  Gangliosides' dual mode of action: a working hypothesis.

Authors:  D Janigro; F Di Gregorio; F Vyskocil; A Gorio
Journal:  J Neurosci Res       Date:  1984       Impact factor: 4.164

7.  Postnatal administration of L-dopa normalizes hypoxia-induced long-term changes in dopamine release from striatum slices and in avoidance learning.

Authors:  A Lun; C Wustmann; C Berndt; H D Fischer; J Gross; K Hecht; G Stamminger; J Schmidt
Journal:  Biomed Biochim Acta       Date:  1986

8.  Inhibitory effects of hypoxia on dopamine release.

Authors:  C Wustmann; H D Fischer; J Schmidt
Journal:  Acta Biol Med Ger       Date:  1982

9.  The pre- and postnatal development of the dopaminergic cell groups in the ventral mesencephalon and the dopaminergic innervation of the striatum of the rat.

Authors:  P Voorn; A Kalsbeek; B Jorritsma-Byham; H J Groenewegen
Journal:  Neuroscience       Date:  1988-06       Impact factor: 3.590

10.  The vulnerable period of perinatal hypoxia with regard to dopamine release and behaviour in adult rats.

Authors:  A Lun; J Gross; M Beyer; H D Fischer; C Wustmann; J Schmidt; K Hecht
Journal:  Biomed Biochim Acta       Date:  1986
View more
  1 in total

1.  Ultrasound findings of mild neonatal periventricular-intraventricular hemorrhage after different treatments.

Authors:  Sida Wang; Chunyan Liao; Shuyuan Liang; Danni Zhong; Junjie Liu; Zhixian Li
Journal:  Int J Clin Exp Med       Date:  2015-04-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.